Review
Nature Reviews Cancer 8, 915-928 (December 2008) | doi:10.1038/nrc2536
Insulin and insulin-like growth factor signalling in neoplasia
There is an Erratum (1 March 2009) associated with this article
Michael Pollak1 About the author
Abstract
Insulin and insulin-like growth factors (IGFs) are well known as key regulators of energy metabolism and growth. There is now considerable evidence that these hormones and the signal transduction networks they regulate have important roles in neoplasia. Epidermiological, clinical and laboratory research methods are being used to investigate novel cancer prevention and treatment strategies related to insulin and IGF signalling. Pharmacological strategies under study include the use of novel receptor-specific antibodies, receptor kinase inhibitors and AMP-activated protein kinase activators such as metformin. There is evidence that insulin and IGF signalling may also be relevant to dietary and lifestyle factors that influence cancer risk and cancer prognosis. Recent results are encouraging and have justified the expansion of many translational research programmes.
- View At a Glance
Author affiliations
-
Department of Oncology, McGill University, Montréal, Québec, Canada.
Email: michael.pollak@mcgill.ca
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
RESEARCH
The interaction of insulin-like growth factor-I with the N-terminal domain of IGFBP-5The EMBO Journal Article (16 Jul 2001)
See all 2 matches for Research